BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 18450228)

  • 1. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.
    Duconge J; Miranda-Massari JR; Gonzalez MJ; Jackson JA; Warnock W; Riordan NH
    P R Health Sci J; 2008 Mar; 27(1):7-19. PubMed ID: 18450228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin C pharmacokinetics: implications for oral and intravenous use.
    Padayatty SJ; Sun H; Wang Y; Riordan HD; Hewitt SM; Katz A; Wesley RA; Levine M
    Ann Intern Med; 2004 Apr; 140(7):533-7. PubMed ID: 15068981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and impact of vitamin C in clinical nutrition.
    McGregor GP; Biesalski HK
    Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):697-703. PubMed ID: 17053422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
    Riordan HD; Casciari JJ; González MJ; Riordan NH; Miranda-Massari JR; Taylor P; Jackson JA
    P R Health Sci J; 2005 Dec; 24(4):269-76. PubMed ID: 16570523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity.
    González MJ; Miranda-Massari JR; Mora EM; Jiménez IZ; Matos MI; Riordan HD; Casciari JJ; Riordan NH; Rodríguez M; Guzmán A
    P R Health Sci J; 2002 Mar; 21(1):39-41. PubMed ID: 12013679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin C metabolites, independent of smoking status, significantly enhance leukocyte, but not plasma ascorbate concentrations.
    Moyad MA; Combs MA; Vrablic AS; Velasquez J; Turner B; Bernal S
    Adv Ther; 2008 Oct; 25(10):995-1009. PubMed ID: 18836692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different levels of vitamin C intake on the vitamin C concentration in guinea pigs plasma and the effect of vitamin C intake on anaphylaxis.
    Pavlović S; Fraser R
    Med Interne; 1988; 26(3):235-44. PubMed ID: 3187363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.
    Ohno S; Ohno Y; Suzuki N; Soma G; Inoue M
    Anticancer Res; 2009 Mar; 29(3):809-15. PubMed ID: 19414313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ascorbic acid concentrations in previously unsupplemented greyhounds after administration of a single dose of ascorbic acid intravenously or per os.
    Scott KC; Hill RC; Lewis DD; Gronwall R; Sundstrom DA; Jones GL; Harper J
    J Anim Physiol Anim Nutr (Berl); 2002 Aug; 86(7-8):222-8. PubMed ID: 15379908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable isotope-labelled vitamin C as a probe for vitamin C absorption by human subjects.
    Bates CJ; Jones KS; Bluck LJ
    Br J Nutr; 2004 May; 91(5):699-705. PubMed ID: 15137921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
    Boothe DM; Perkins J
    J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of high-dose intravenous vitamin C as an anticancer agent.
    Wilson MK; Baguley BC; Wall C; Jameson MB; Findlay MP
    Asia Pac J Clin Oncol; 2014 Mar; 10(1):22-37. PubMed ID: 24571058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker.
    Washio K; Inagaki M; Tsuji M; Morio Y; Akiyama S; Gotoh H; Gotoh T; Gotoh Y; Oguchi K
    Nephron Clin Pract; 2008; 109(2):c49-54. PubMed ID: 18544955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The controversial place of vitamin C in cancer treatment.
    Verrax J; Calderon PB
    Biochem Pharmacol; 2008 Dec; 76(12):1644-52. PubMed ID: 18938145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs.
    Casciari JJ; Riordan HD; Miranda-Massari JR; Gonzalez MJ
    P R Health Sci J; 2005 Jun; 24(2):145-50. PubMed ID: 16116933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin C-lipid metabolites: uptake and retention and effect on plasma C-reactive protein and oxidized LDL levels in healthy volunteers.
    Pancorbo D; Vazquez C; Fletcher MA
    Med Sci Monit; 2008 Nov; 14(11):CR547-51. PubMed ID: 18971870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vitamin C in complementary oncology--update 2009].
    Gröber U
    Med Monatsschr Pharm; 2009 Jul; 32(7):263-7. PubMed ID: 19731754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects.
    Verrax J; Calderon PB
    Free Radic Biol Med; 2009 Jul; 47(1):32-40. PubMed ID: 19254759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.